The Patent Finder

Verastem, Inc.

Also on record
Records under this name other than the patents Verastem, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.

Showing 1 to 6 of 6 · Back to Verastem, Inc.

PatentTitleStatus Expires Confidence
US 9,138,437Pyrimidine substituted purine compounds as kinase (S) inhibitors
Lapsed on the fee record
Ended Sep 22, 2023 · From the USPTO record
Lapsed on the fee recordEnded Sep 22, 2023From the USPTO record
US 8,754,080Pyrimidine substituted purine compounds as kinase (S) inhibitors
Lapsed on the fee record
Ended Jun 17, 2022 · From the USPTO record
Lapsed on the fee recordEnded Jun 17, 2022From the USPTO record
US 8,609,838Pyrimidine substituted purine derivatives
Lapsed on the fee record
Ended Dec 17, 2021 · From the USPTO record
Lapsed on the fee recordEnded Dec 17, 2021From the USPTO record
US 9,505,719Synthesis and use of kinase inhibitors
Lapsed on the fee record
Ended Nov 29, 2020 · From the USPTO record
Lapsed on the fee recordEnded Nov 29, 2020From the USPTO record
US 8,247,410Pyrimidine substituted purine derivatives
Lapsed on the fee record
Ended Aug 21, 2020 · From the USPTO record
Lapsed on the fee recordEnded Aug 21, 2020From the USPTO record
US 9,375,402Oral formulations of kinase inhibitors
Lapsed on the fee record
Ended Jun 28, 2020 · From the USPTO record
Lapsed on the fee recordEnded Jun 28, 2020From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited